Nicholas Investment Partners’s Dermira, Inc. DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-124,068
Closed -$1.14M 259
2018
Q2
$1.14M Sell
124,068
-923
-0.7% -$8.6K 0.08% 213
2018
Q1
$999K Buy
124,991
+31,163
+33% +$678K 0.07% 221
2017
Q4
$2.61M Sell
93,828
-60,902
-39% -$1.62M 0.17% 183
2017
Q3
$4.18M Buy
154,730
+27,726
+22% +$726K 0.29% 108
2017
Q2
$3.7M Buy
127,004
+20,587
+19% +$626K 0.26% 129
2017
Q1
$3.63M Sell
106,417
-27,525
-21% -$888K 0.26% 137
2016
Q4
$4.06M Sell
133,942
-20,214
-13% -$651K 0.31% 127
2016
Q3
$5.21M Buy
154,156
+43,055
+39% +$1.39M 0.35% 87
2016
Q2
$3.25M Buy
111,101
+25,758
+30% +$711K 0.23% 183
2016
Q1
$1.76M Buy
85,343
+14,373
+20% +$353K 0.13% 255
2015
Q4
$2.46M Buy
+70,970
New +$2.04M 0.17% 227

Other funds holding DERM

Nicholas Investment Partners's DERM Position: Q3 2018 in Review

Nicholas Investment Partners sold out of Dermira, Inc. (DERM) in Q3 2018, closing a stake of 124,068 shares — an estimated $1.14M sold.

Nicholas Investment Partners first reported a position in DERM in Q4 2015 and held it in 11 quarters. The position peaked at $5.21M in Q3 2016. 105 funds tracked by Wall St. Rank hold DERM as of Q3 2018.

  • Nicholas Investment Partners reported no remaining Dermira, Inc. position as of Q3 2018 after selling out during the quarter.
  • Nicholas Investment Partners sold 124,068 Dermira, Inc. shares in Q3 2018, an estimated $1.14M.
  • Nicholas Investment Partners first reported a position in Dermira, Inc. in Q4 2015 and held it in 11 quarters.
  • Nicholas Investment Partners's Dermira, Inc. position peaked at $5.21M in Q3 2016.
  • 105 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2018.

Based on Nicholas Investment Partners's 13F filing for Q3 2018, filed 14 Nov 2018.